Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
Epigenetics. 2021 Jun;16(6):677-691. doi: 10.1080/15592294.2020.1819661. Epub 2020 Sep 24.
Age-related DNA methylation is a potential mechanism contributing to breast cancer development. Studies of primarily Caucasian women have identified many CpG sites of age-related methylation in non-diseased breast tissue possibly driving cancer development over time. There is a paucity of studies involving Asian women whose ages at breast cancer onset are usually younger than Caucasians. We identified the 181 most consistent age-related methylation events in non-diseased breast tissue across published studies. Age-related methylation events were measured in adjacent normal and breast tumour tissue in an exclusively Asian population at the previously identified age-related methylation sites. Age-related methylation was found in 118 probes in adjacent normal breast tissue. Methylation of 99% of these sites was increased with age and predominantly located on CpG islands in promoter regions. To ascertain biological relevance to breast cancer, we focused on the 37 sites with overall higher methylation in tumour compared to adjacent normal samples. Some sites positively related to age, including and , inversely correlated with gene expression. Several others have known involvement in suppression of carcinogenesis including and , suggesting that perturbation of epigenetic regulation at these sites due to ageing may contribute to the progression of carcinogenesis. This study highlights an age-related methylation landscape in non-tumour tissue, consistent not just across studies, but also across different populations. We present candidate age-related methylation sites warranting further investigation as potential epigenetic drivers of breast cancer. They may serve as potential targets of site-specific demethylation intervention strategies for the prevention of age-related breast cancer.
年龄相关的 DNA 甲基化是导致乳腺癌发生的潜在机制。主要针对白种人女性的研究已经确定了许多非病变乳腺组织中与年龄相关的甲基化 CpG 位点,这些位点可能随着时间的推移导致癌症的发生。涉及亚洲女性的研究很少,亚洲女性的乳腺癌发病年龄通常比白种人年轻。我们在已发表的研究中确定了 181 个在非病变乳腺组织中最一致的与年龄相关的甲基化事件。在先前确定的与年龄相关的甲基化位点,在一个完全由亚洲人组成的人群中,对相邻的正常和乳腺肿瘤组织进行了与年龄相关的甲基化事件的测量。在相邻的正常乳腺组织中发现了 118 个探针的与年龄相关的甲基化。这些位点中 99%的甲基化随着年龄的增长而增加,主要位于启动子区域的 CpG 岛上。为了确定与乳腺癌的生物学相关性,我们将重点放在肿瘤与相邻正常样本相比总体甲基化程度更高的 37 个位点上。一些与年龄呈正相关的位点,包括和 ,与基因表达呈负相关。其他一些已知与抑制致癌作用有关,包括和 ,这表明由于衰老导致这些位点的表观遗传调控受到干扰,可能会促进致癌作用的进展。本研究强调了非肿瘤组织中的年龄相关甲基化图谱,不仅在研究之间一致,而且在不同人群之间也一致。我们提出了一些候选的与年龄相关的甲基化位点,这些位点值得进一步研究,作为乳腺癌的潜在表观遗传驱动因素。它们可能成为针对特定部位去甲基化干预策略的潜在靶点,以预防与年龄相关的乳腺癌。